References
- Fernández-Cuenca F, Martínez-Martínez L, Conejo MC, et al. Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother. 2003;51:565–574.
- Rawat D, Nair D. Extended-spectrum β-lactamases in Gram negative bacteria. J Glob Infect Dis. 2010;2(3):263–265.
- Yong D, Shin JH, Kim S, et al. High prevalence of PER-1 extended-spectrum beta-lactamase–producing Acinetobacter spp. in Korea. Antimicrob Agents Chemother. 2003;47:1749–1751.
- Thomson KS. Extended-Spectrum-Lactamase, AmpC, and Carbapenemase Issues. J Clin Microbiol. 2010;4:1019–1025.
- Suresh K, Chandrashekara S. Sample size estimation and power analysis for clinical research studies. J Hum Reprod Sci. 2012;5:7–13.
- Clinical Laboratory Standards Institute [CLSI]. 2012. Table 3A:M02-A12 and M07-A10. Available from: https://clsi.org/ Access date: 1st October 2013.
- Kahlmeter G. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae EUCAST and CLSI breakpoints. Clin Microbiol Infect. 2008;14(1):169–174.
- Kansal R, Pandey A, Asthana AK. Beta-lactamase producing Acinetobacter species in hospitalized patients. Indian J Pathol Microbiol. 2009;52:456–457.
- Szabo D, Szentandrassy J, Juhasz Z, et al. Imported PER-1 producing Pseudomonas aeruginosa. PER-1 producing Acinetobacter baumannii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary. Ann Clin Microbiol Antimicrob. 2008;7:12.
- Bazargani A, Hashemizadeh Z. Bacteremia due to multidrug-resistant (MDR) and extended-spectrum beta-lactamase (ESBL) producing Acinetobacter baumannii. Afr J Microbiol Res. 2011;5(21):3483–3486.
- Nagano N, Nagano Y, Cordevant C, et al. Nosocomial transmission of CTX-M-2 β-lactamase producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol. 2004;42:3978–3984.
- Essam Alyamani J, Khiyami MA, Rayan Booq Y, et al. Molecular characterization of extended‑spectrum beta‑lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia. Ann Clin Microbiol Antimicrob. 2015;14:38–45.
- Marzieh S, Nejad ASM, Bahador A, et al. Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU) Saudi. J Biol Sci. 2015;22(4):424–429.
- Bali NK, Fomda BA, Bashir H, et al. Emergence of carbapenem-resistant Acinetobacter in a temperate north Indian State. Br J Biomed Sci. 2013;70(4):156–160.
- Naas T, Cuzon G, Bogaerts P, et al. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Microbiol. 2011;49(4):1608–1613.